Click it and Unblock the Notifications
Latest Updates
-
Deepika Padukone And Ranveer Singh Announce Second Daughter’s Name On Dussehra, Share Family Photo -
Who Was Karthik Sabesh? Tamil Actor Passes Away At 37, Days After Uncle And Composer Deva’s Death -
Who Is Ravleen Varghese? Meet The First Malayali Model To Walk The Victoria’s Secret Runway -
World Osteoporosis Day 2026: A Minor Fall, A Major Fracture — Doctor On Why Older Adults Should Be Careful -
Durga Visarjan 2026: October 20 or 21? Know Shubh Muhurat, Rituals And Significance -
Happy Dussehra 2026: 50+ Wishes, Messages And Greetings To Share With Family And Friends -
Dussehra 2026: Astrologer Ashutosh Clairvoyant On Colours, Offerings And Puja Rituals For Each Zodiac Sign -
Hustle Culture Has a Bedroom Problem No One Talks About, Expert Explains -
Iris Young Minds Initiative: How A Noida CSR Programme Is Opening Up Talk On Student Stress -
Lal Hit Janta Party Explained: Who Is Behind The Rival to the Cockroach Janta Party
Gene Therapy For Blindness Improves Vision
Researchers from University of Florida and University of Pennsylvania have successfully able to restore vision among patients with a rare form of congenital blindness using gene therapy, thus showing that the treatment is fully safe.
In Leber Congenital Amaurosis type 2 disease, photoreceptor cells cannot respond to light because a gene called RPE65 does not properly produce a protein necessary for healthy vision.
Researchers used an adeno-associated virus — an apparently harmless virus that already exists in most people to deliver RPE65 to a small area of the retina. The results showed that not only were there no ill effects other than routine post surgical soreness, the vision in the subjects" treated eyes was slightly improved in dim lighting conditions.
"The patients report seeing brighter areas and perhaps some images, but basically the message is that this is treatment is fully safe," said William W. Hauswirth, Ph.D., a professor of ophthalmology and member of UF's Powell Gene Therapy Centre and the UF Genetics Institute.
"One thing we did not do is suppress the patients' immune systems, which was done in two other LCA clinical trials that were under way," said Hauswirth, who began studying the adeno-associated virus as a vehicle to deliver genes into living animals more than 30 years ago.
"Theoretically, the idea was that it might be necessary to suppress the immune system because we are using a vector that might activate the body's defenses and cause a harmful response.
"However, immune suppression itself carries a risk of infections and other problems. Clearly we have shown there is no need to do that in this case," he added.
"The study has partially restored vision in three young adults, and it demonstrates that gene therapy can be effective in treating human vision disease," said Paul A. Sieving, M.D., Ph.D., director, National Eye Institute of the National Institutes of Health. The paper is published online today in Human Gene Therapy.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
Continue with Google
